International Flavors & Fragrances Inc.

International Flavors & Fragrances Inc. (IFF) Market Cap

International Flavors & Fragrances Inc. has a market capitalization of $19.39B.

Financials based on reported quarter end 2025-12-31

Price: $75.88

3.82 (5.30%)

Market Cap: 19.39B

NYSE · time unavailable

CEO: Jon Erik Fyrwald

Sector: Basic Materials

Industry: Chemicals - Specialty

IPO Date: 1974-12-17

Website: https://www.iff.com

International Flavors & Fragrances Inc. (IFF) - Company Information

Market Cap: 19.39B · Sector: Basic Materials

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines. The Health & Biosciences segment develops and produces enzymes, food cultures, probiotics, and specialty ingredients. The Pharma Solutions segment produces and sells cellulosics and seaweed-based pharma excipients. The company sells its products primarily to manufacturers of perfumes and cosmetics, hair and other personal care products, soaps and detergents, cleaning products, dairy, meat and other processed foods, beverages, snacks and savory foods, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional food, and pharmaceutical excipients and oral care products. International Flavors & Fragrances Inc. was founded in 1833 and is headquartered in New York, New York.

Analyst Sentiment

81%
Strong Buy

Based on 19 ratings

Analyst 1Y Forecast: $83.88

Average target (based on 3 sources)

Consensus Price Target

Low

$75

Median

$91

High

$97

Average

$88

Potential Upside: 15.6%

Price & Moving Averages

Loading chart...

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 International Flavors & Fragrances Inc. (IFF) — Investment Overview

🧩 Business Model Overview

International Flavors & Fragrances Inc. (IFF) is a leading global creator and manufacturer of flavors, fragrances, and specialty ingredients, serving a broad array of industries including food and beverage, personal care, home care, and health & wellness. IFF collaborates directly with consumer goods companies, food producers, and other industrial partners to co-develop products that enhance sensory experiences. Its research-driven approach, supported by state-of-the-art testing and formulation centers, positions IFF as a critical supplier and innovation partner in the value chain of fast-moving consumer goods worldwide.

💰 Revenue Model & Ecosystem

IFF's revenue model is inherently diversified, deriving sales from a broad mix of product categories, customer segments, and geographic markets. Recurring revenue stems from long-term supply agreements and embedded partnerships with consumer products companies. The nature of IFF’s offerings—whether bespoke flavors for beverages, complex fragrance compounds for personal care, or functional ingredients for health applications—creates durable, repeat business. As an ingredient supplier, IFF integrates into its customers’ innovation cycles, offering technical consulting and formulation services that further solidify customer loyalty and ecosystem interconnectedness.

🧠 Competitive Advantages

  • Brand strength: IFF is widely recognized for high-quality, innovative solutions, and long-standing relationships with many of the world’s best-known consumer brands.
  • Switching costs: Product formulations often require regulatory approval and consumer testing, making it complex for customers to shift suppliers without significant cost and risk.
  • Ecosystem stickiness: Deep technical integration and co-development cycles embed IFF directly within customers’ R&D and product launch processes.
  • Scale + supply chain leverage: As one of the largest players globally, IFF enjoys benefits of global procurement, efficient production, and investment in advanced R&D facilities that smaller peers cannot easily replicate.

🚀 Growth Drivers Ahead

IFF is poised to benefit from multi-year trends such as the increasing demand for healthier, natural, and sustainable ingredients across food and personal care. Expansion into adjacent markets—including functional health ingredients and plant-based solutions—represents an opportunity to capture share as consumer preferences evolve. Ongoing investment in research, biosciences, and technology platforms also supports the company's ability to co-innovate with customers, particularly in emerging markets where lifestyle changes are fueling new demand. Strategic acquisitions and global partnerships continue to broaden IFF’s portfolio and market reach.

⚠ Risk Factors to Monitor

Key risks include intense industry competition from both established multinationals and specialized regional players, which could exert ongoing pressure on pricing and margins. Shifting regulatory landscapes, particularly regarding flavor and fragrance ingredients, may require continual reformulation and compliance investments. Changes in consumer preferences and technological disruption (such as alternative production methods or synthetic biology entrants) could potentially impact legacy business lines. Furthermore, supply chain volatility and input cost inflation remain important operational challenges to watch.

📊 Valuation Perspective

The market tends to value IFF in line with global consumer ingredient peers, factoring in its brand quality, innovation pipeline, and established customer relationships. Perceived as a premium supplier with stable end-market demand, IFF often commands a valuation that reflects its defensive growth profile, diversified revenue streams, and global scale. Investors weigh its ability to generate consistent cash flow and leverage its innovation platforms against periodic industry cyclicality and structural shifts in consumer tastes.

🔍 Investment Takeaway

The investment thesis for IFF centers on its position as a strategic partner to leading consumer brands, supported by deep technical expertise and entrenched customer relationships. Bullish arguments highlight IFF’s innovation-led growth, expanding addressable markets, and strong barriers to entry in a demand-resilient industry. However, risks surrounding margin compression, regulatory changes, and the pace of consumer trends present ongoing challenges. Overall, IFF offers investors exposure to global consumer staples innovation, balanced by the complexities of ingredient supply dynamics and the need for continual adaptation.


⚠ AI-generated research summary — not financial advice. Validate using official filings & independent analysis.

IFF delivered a solid Q4 and FY25 with modest top-line growth, stronger EBITDA and margin expansion, and significant deleveraging. Segment performance was broad-based, highlighted by Taste and Health & Biosciences, while commodity Fragrance Ingredients and parts of Food Ingredients remained soft. The company advanced portfolio optimization and launched the Food Ingredients sale process, while reinvesting in innovation and capacity. 2026 guidance calls for volume-led growth, margin improvement, and better cash generation, with a more muted first half and elevated transaction costs. Management’s tone is cautiously optimistic amid ongoing macro and pricing pressures.

Growth

  • Q4 revenue ~$2.6B, +1% cc vs. +6% prior-year comp; two-year avg +4%
  • Q4 EBITDA $437M, +7% y/y; margin 16.9% (+90 bps)
  • FY25 EBITDA +7% with +100 bps margin expansion
  • Taste: FY25 sales +4%, EBITDA +10%; Q4 sales $588M +2%, EBITDA $94M +17%
  • Health & Biosciences: FY25 sales +3%, EBITDA +7%; Q4 sales $589M +5%, EBITDA $155M +20%
  • Scent: FY25 sales +3%, EBITDA +2%; Q4 sales $610M +4%, EBITDA $106M +1%
  • Food Ingredients: FY25 EBITDA +10% with +150 bps margin despite lower sales; Q4 sales $802M -4%, EBITDA $82M -11%
  • Q4 Fine Fragrance +10%; Consumer Fragrance mid-single-digit; Food Biosciences & Animal Nutrition double-digit; Home & Personal Care high single-digit
  • North America Taste Q4 high single-digit growth on new wins

Business Development

  • Completed divestitures of Pharma Solutions, nitrocellulose, and René Laurent
  • Signed agreement to sell soy crush concentrates and lecithin to Bunge (expected by April)
  • Launched competitive sale process for Food Ingredients; not under pressure to sell
  • Proactively exited low-margin business in Food Ingredients
  • Health & Biosciences operating under new leadership with improvement plan underway

Financials

  • Q4 revenue ~$2.6B; EBITDA $437M; margin 16.9% (+90 bps)
  • FY25 cash from operations $850M; CapEx $594M (~5.5% of sales)
  • FY25 free cash flow $256M, including ~$300M of one-time (Reg G) costs tied to divestitures
  • Working capital outflow ~$166M (inventory, AR/AP changes); improvement actions underway
  • TTM credit-adjusted EBITDA ~$2.1B

Capital & Funding

  • Year-end cash ~$590M; gross debt ~$(6.0)B, down ~$(3.0)B vs. 2024
  • Net debt / credit-adjusted EBITDA 2.6x (vs. 3.8x in 2024)
  • Returned $409M via dividends and $38M via share repurchases in 2025; plan to at least offset $80–$100M annual dilution
  • Focused capital allocation toward deleveraging and targeted reinvestment

Operations & Strategy

  • Ongoing productivity, cost discipline, and digital/AI-enabled operational excellence to fund growth
  • Reinvestment in R&D, commercial capabilities, enzyme capacity, naturals, and new molecules (biotech/AI-powered)
  • Shift Fragrance Ingredients mix toward higher-value specialties and delivery systems
  • Strengthening Health commercial execution; improvement plan in place
  • Working capital and cash flow prioritized; 2026 incentives include OCF conversion metric
  • CapEx planned at ~6% of sales in 2026 focused on capacity, network optimization, and innovation

Market & Outlook

  • 2026 sales guidance $10.5–$10.8B (+1% to +4% cc) with volume-led growth across Taste, Health & Biosciences, and Scent
  • 2026 EBITDA guidance $2.05–$2.15B (+3% to +8% cc); selective reinvestment funded by productivity
  • FX expected +~1 pt to sales and negligible impact to EBITDA in 2026
  • 1H26 (especially Q1) more muted due to tough comps and divestiture effects; sequential improvement through the year
  • Operating cash flow expected to improve y/y excluding one-time costs; Reg G/transaction costs likely higher in 2026 given potential Food Ingredients sale

Risks Or Headwinds

  • Persistent macroeconomic and geopolitical uncertainty
  • Price competition and softness in commodity Fragrance Ingredients
  • Soft demand in Protein Solutions and Emulsifiers & Sweeteners; Russia sanctions impacting Emulsifiers
  • Higher one-time (Reg G) costs tied to portfolio actions in 2026
  • Working capital management execution risk; tougher 1H26 comparisons
  • Transaction execution risk around Food Ingredients sale

Sentiment: CAUTIOUS

Note: This summary was synthesized by AI from the IFF Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Fundamentals Overview

Loading fundamentals overview...

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2025-12-31

"In the most recent quarter, International Flavors & Fragrances reported revenue of $2.589 billion and a net income of $18 million, translating to an EPS of $0.07 and a net margin of approximately 0.7%. The company generated $30 million in free cash flow (FCF). Compared to previous periods, growth appears moderate with stability challenges highlighted by the low net margin. Profitability is under pressure, as indicated by the slender EPS. However, the company remains liquid with a positive operating cash flow of $164 million. Balance sheet resilience is supported by total assets of $25.537 billion against liabilities of $8.673 billion, delivering an equity ratio of 100%, though net debt stands at $5.404 billion, suggesting manageable leverage. Valuation indicators such as the absence of a P/E ratio and FCF yield in the provided dataset imply caution. Analyst price targets reflect moderate optimism with a consensus at $76, slightly above recent price levels, indicating potential appreciation. Dividends suggest a commitment to shareholder returns, maintaining steady quarterly distributions totaling $1.60 annually."

Revenue Growth

Fair

Revenue grew moderately to $2.589 billion. Growth stability is a concern given the industry's competitive dynamics.

Profitability

Caution

Net income of $18 million and an EPS of $0.07 indicate pressure on margins and profit efficiency.

Cash Flow Quality

Positive

Positive operating cash flow of $164 million and $30 million in FCF indicate adequate liquidity. Steady dividends are supported.

Leverage & Balance Sheet

Neutral

A balance sheet showing total assets matching equity suggests stability, but $5.4 billion in net debt requires attention.

Shareholder Returns

Positive

Consistent dividend payments enhance returns, totaling $1.60 per share annually. No buybacks occurred.

Analyst Sentiment & Valuation

Positive

Analyst targets average at $76, indicating positive sentiment. Valuation remains cautious due to limited profitability.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Loading financial data and tables...
📁

SEC Filings (IFF)

© 2026 Stock Market Info — International Flavors & Fragrances Inc. (IFF) Financial Profile